Let-7b regulates the adriamycin resistance of chronic myelogenous leukemia by targeting AURKB in K562/ADM cells

References

• Hochhaus A, Saussele S, Rosti G, ESMO Guidelines Committee, et al. Chronic myeloid leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv41–iv51.
   PubMed Web of Science ®Google Scholar
• Bartram CR, de Klein A, Hagemeijer A, et al. Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature. 1983;306(5940):277–280.
   PubMed Web of Science ®Google Scholar
• He S-J, Shu L-P, Zhou Z-W, et al. Inhibition of Aurora kinases induces apoptosis and autophagy via AURKB/p70S6K/RPL15 axis in human leukemia cells. Cancer Lett. 2016;382(2):215–230.
   PubMed Web of Science ®Google Scholar
• Aluigi A, Ballestri M, Guerrini A, et al. Organic solvent-free preparation of keratin nanoparticles as doxorubicin carriers for antitumour activity. Mater Sci Eng C Mater Biol Appl. 2018;90:476–484.
   PubMed Web of Science ®Google Scholar
• Liu W, He J, Yang Y, et al. Upregulating miR-146a by physcion reverses multidrug resistance in human chronic myelogenous leukemia K562/ADM cells. Am J Cancer Res. 2016;6(11):2547–2560.
   PubMed Web of Science ®Google Scholar
• Savona M, Talpaz M. Getting to the stem of chronic myeloid leukaemia. Nat Rev Cancer. 2008;8(5) :341–350.
   PubMed Web of Science ®Google Scholar
• Nilsen TW. Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet. 2007;23(5):243–249.
   PubMed Web of Science ®Google Scholar
• Boehm M, Slack F. A developmental timing microRNA and its target regulate life span in C. elegans. Science. 2005;310(5756):1954–1957.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
   PubMed Web of Science ®Google Scholar
• Roush S, Slack FJ. The let-7 family of microRNAs. Trends Cell Biol. 2008;18(10):505–516.
   PubMed Web of Science ®Google Scholar
• Lee H, Han S, Kwon CS, et al. Biogenesis and regulation of the let-7 miRNAs and their functional implications. Protein Cell. 2016;7(2):100–113.
   PubMed Web of Science ®Google Scholar
• Tang H, Ma M, Dai J, et al. miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy. J Exp Clin Cancer Res. 2019;38(1):212.
   PubMedGoogle Scholar
• Han X, Zhang J-J, Han Z-Q, et al. Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB. Cancer Gene Ther. 2018;25(11-12):300–308.
   PubMed Web of Science ®Google Scholar
• Balboula AZ, Schindler K. Selective disruption of aurora C kinase reveals distinct functions from aurora B kinase during meiosis in mouse oocytes. PLoS Genet. 2014;10(2):e1004194.
   PubMed Web of Science ®Google Scholar
• Nguyen AL, Schindler K. Specialize and divide (Twice): functions of three aurora kinase homologs in mammalian oocyte meiotic maturation. Trends Genet. 2017;33(5):349–363.
   PubMed Web of Science ®Google Scholar
• Schecher S, Walter B, Falkenstein M, et al. Cyclin K dependent regulation of Aurora B affects apoptosis and proliferation by induction of mitotic catastrophe in prostate cancer. Int J Cancer. 2017;141(8):1643–1653.
   PubMed Web of Science ®Google Scholar
• Mesic A, Markocic E, Rogar M, et al. Single nucleotide polymorphisms rs911160 in AURKA and rs2289590 in AURKB mitotic checkpoint genes contribute to gastric cancer susceptibility. Environ Mol Mutagen. 2017;58(9):701–711.
   PubMed Web of Science ®Google Scholar
• Huang D, Huang Y, Huang Z, et al. Relation of AURKB over-expression to low survival rate in BCRA and reversine-modulated aurora B kinase in breast cancer cell lines. Cancer Cell Int. 2019;19(1):166.
   PubMedGoogle Scholar
• Bertran-Alamillo J, Cattan V, Schoumacher M, et al. AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy. Nat Commun. 2019;10(1):1812.
   PubMedGoogle Scholar
• Yu X, Liang Q, Liu W, et al. Deguelin, an aurora B kinase inhibitor, exhibits potent anti-tumor effect in human esophageal squamous cell carcinoma. EBioMedicine. 2017;26:100–111.
   PubMed Web of Science ®Google Scholar
• Liu C, Feng Z, Chen T, et al. Downregulation of NEAT1 reverses the radioactive iodine resistance of papillary thyroid carcinoma cell via miR-101-3p/FN1/PI3K-AKT signaling pathway. Cell Cycle. 2019;18(2):167–203.
   PubMed Web of Science ®Google Scholar
• Li S-L, Chen X, Wu T, et al. Knockdown of TMPRSS3 inhibits gastric cancer cell proliferation, invasion and EMT via regulation of the ERK1/2 and PI3K/Akt pathways. Biomed Pharmacother. 2018;107:841–848.
   PubMed Web of Science ®Google Scholar
• Ma X, Zhou X, Qu H, et al. TRIB2 knockdown as a regulator of chemotherapy resistance and proliferation via the ERK/STAT3 signaling pathway in human chronic myelogenous leukemia K562/ADM cells. Oncol Rep. 2018;39(4):1910–1918.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang P, Yuan M, et al. Overexpression of miRNA-21 promotes the proliferation and invasion in hepatocellular carcinoma cells via suppressing SMAD7. Technol Cancer Res Treat. 2019;18:1533033819878686.
   Web of Science ®Google Scholar
• Tang J, et al. miR-204-5p regulates cell proliferation, invasion, and apoptosis by targeting IL-11 in esophageal squamous cell carcinoma. J Cell Physiol. 2020;235(3):3043–3055.
   PubMed Web of Science ®Google Scholar
• Mardani R, Jafari Najaf Abadi MH, Motieian M, et al. MicroRNA in leukemia: tumor suppressors and oncogenes with prognostic potential. J Cell Physiol. 2019;234(6):8465–8486.
   PubMed Web of Science ®Google Scholar
• Emmrich S, Katsman-Kuipers JE, Henke K, et al. miR-9 is a tumor suppressor in pediatric AML with t(8;21). Leukemia. 2014;28(5):1022–1032.
   PubMed Web of Science ®Google Scholar
• Zhang K, Wang W, Liu Y, et al. Let-7b acts as a tumor suppressor in osteosarcoma via targeting IGF1R. Oncol Lett. 2019;17(2):1646–1654.
   PubMed Web of Science ®Google Scholar
• He Z, Deng W, Jiang B, et al. Hsa-let-7b inhibits cell proliferation by targeting PLK1 in HCC. Gene. 2018;673:46–55.
   PubMed Web of Science ®Google Scholar
• Lu L, Wu M, Lu Y, et al. MicroRNA-424 regulates cisplatin resistance of gastric cancer by targeting SMURF1 based on GEO database and primary validation in human gastric cancer tissues. OTT. 2019;12:7623–7636.
   Google Scholar
• Yuan X, Ma R, Yang S, et al. miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1. Cell Cycle. 2019;18(14):1660–1669.
   PubMed Web of Science ®Google Scholar
• Sun H, Fan G, Deng C, et al. miR-4429 sensitized cervical cancer cells to irradiation by targeting RAD51. J Cell Physiol. 2020;235(1):185–193.
   PubMed Web of Science ®Google Scholar
• Zekri A, Ghaffari SH, Yaghmaie M, et al. Inhibitor of aurora kinase B induces differentially cell death and polyploidy via DNA damage response pathways in neurological malignancy: shedding new light on the challenge of resistance to AZD1152-HQPA. Mol Neurobiol. 2016;53(3):1808–1823.
   PubMed Web of Science ®Google Scholar
• Liu L, Jiang X, Yu W. Dracohodin perochlorate stimulates fibroblast proliferation via EGFR activation and downstream ERK/CREB and PI3K/Akt/mTOR pathways in vitro. Evid Based Complement Alternat Med. 2019;2019:1–11.
   Web of Science ®Google Scholar
• Salt MB, Bandyopadhyay S, McCormick F. Epithelial-to-mesenchymal transition rewires the molecular path to PI3K-dependent proliferation. Cancer Discov. 2014;4(2):186–199.
   PubMed Web of Science ®Google Scholar